Class IITerminatedD-0412-2022
Drug recall · February 2, 2022
MVASI, (bevacizumab-awwb) recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL (25 mg/mL) 0.13 mL per syringe, Dose: 1.25mg/0.05mL, Single Use Syringe For Intraocular Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1661-13
- Lots / codes
11-2021-01@2 12/15/2021
- Quantity
- 199 syringes
- Company
- Edge Pharma, LLC, Colchester, VT
- Distribution
- nationwide
- Initiated
- December 6, 2021 · Voluntary: Firm initiated
- Classified
- January 24, 2022
- Reported
- February 2, 2022
- Ended
- June 7, 2023
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedFeb 2, 2022ALUM ConcentrateEdge Pharma, LLC · D-0394-2022Class IITerminatedFeb 2, 2022Lidocaine HCl Sterile Buffered Solution for InjectionEdge Pharma, LLC · D-0395-2022Class IITerminatedFeb 2, 2022Lidocaine HCl/EpinephrineEdge Pharma, LLC · D-0396-2022Class IITerminatedFeb 2, 2022CeftazidimeEdge Pharma, LLC · D-0397-2022Class IITerminatedFeb 2, 2022CefuroximeEdge Pharma, LLC · D-0398-2022Class IITerminatedFeb 2, 2022Dexamethasone sodium phosphateEdge Pharma, LLC · D-0399-2022Class IITerminatedFeb 2, 2022Edetate DisodiumEdge Pharma, LLC · D-0400-2022Class IITerminatedFeb 2, 2022Edetate DisodiumEdge Pharma, LLC · D-0401-2022Class IITerminatedFeb 2, 2022Epinephrine/Lidocaine HCl Sterile Ophthalmic Solution for InjectionEdge Pharma, LLC · D-0402-2022Class IITerminatedFeb 2, 2022GemcitabineEdge Pharma, LLC · D-0403-2022Class IITerminatedFeb 2, 2022Lidocaine HCL / Bupivacaine HCLEdge Pharma, LLC · D-0404-2022Class IITerminatedFeb 2, 2022Methacholine Challenge 5-Syringe Test KitEdge Pharma, LLC · D-0405-2022
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.